DESIGN. ANALYZE. ADVANCE. Trademark

Trademark Overview


On Monday, August 4, 2025, a trademark application was filed for DESIGN. ANALYZE. ADVANCE. with the United States Patent and Trademark Office. The USPTO has given the DESIGN. ANALYZE. ADVANCE. trademark a serial number of 99318283. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 7, 2026. This trademark is owned by BIOMEDICAL STATISTICAL CONSULTING IP LLC. The DESIGN. ANALYZE. ADVANCE. trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Representation of clients in biomedical and pharmaceutical regulatory proceedings

Promoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries for others regarding clinical trials

Consulting services for pharmaceutical, medical device, biotechnology, and medical research industries; consulting services in the field of expert review of proposed clinical trial design; software as a service (SaaS) featuring software for statistical analysis and simulation tools for clinical trial design, analysis, and optimization; providing an online non-downloadable computer software platform for running in vivo studies; providing an online non-downloadable computer software platform for running in silico studies; data modeling and statistical consulting services for the pharmaceutical, medical device, biotechnology, and medical research industries; design, development and implementation of software for in vivo simulations; design, development and implementation of software for in silico simulations
design. analyze. advance.

General Information


Serial Number99318283
Word MarkDESIGN. ANALYZE. ADVANCE.
Filing DateMonday, August 4, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2026

Trademark Statements


NOT AVAILABLE"DESIGN" and "ANALYZE"
Goods and ServicesRepresentation of clients in biomedical and pharmaceutical regulatory proceedings
Pseudo MarkDESIGN ANALYZE ADVANCE
Goods and ServicesPromoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries for others regarding clinical trials
Goods and ServicesConsulting services for pharmaceutical, medical device, biotechnology, and medical research industries; consulting services in the field of expert review of proposed clinical trial design; software as a service (SaaS) featuring software for statistical analysis and simulation tools for clinical trial design, analysis, and optimization; providing an online non-downloadable computer software platform for running in vivo studies; providing an online non-downloadable computer software platform for running in silico studies; data modeling and statistical consulting services for the pharmaceutical, medical device, biotechnology, and medical research industries; design, development and implementation of software for in vivo simulations; design, development and implementation of software for in silico simulations

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, August 4, 2025
Primary Code035
First Use Anywhere DateThursday, July 24, 2025
First Use In Commerce DateThursday, July 24, 2025

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 4, 2025
Primary Code042
First Use Anywhere DateThursday, July 24, 2025
First Use In Commerce DateThursday, July 24, 2025

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 4, 2025
Primary Code045
First Use Anywhere DateThursday, July 24, 2025
First Use In Commerce DateThursday, July 24, 2025

Trademark Owner History


Party NameBIOMEDICAL STATISTICAL CONSULTING IP LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPHILADELPHIA, PA 19103
US

Trademark Events


Event DateEvent Description
Monday, August 4, 2025NEW APPLICATION ENTERED
Monday, August 4, 2025APPLICATION FILING RECEIPT MAILED
Thursday, December 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 17, 2025ASSIGNED TO EXAMINER
Friday, March 20, 2026NON-FINAL ACTION WRITTEN
Friday, March 20, 2026NON-FINAL ACTION E-MAILED
Friday, March 20, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 30, 2026EXAMINERS AMENDMENT -WRITTEN
Monday, March 30, 2026EXAMINERS AMENDMENT E-MAILED
Monday, March 30, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 30, 2026EXAMINER'S AMENDMENT ENTERED
Monday, March 30, 2026APPROVED FOR PUB - PRINCIPAL REGISTER